Taken together, these results indicate that YAP signaling in cancer cells, enhanced by steatotic liver through HAS2-mediated HA production, feeds back to promote CAF activation, including HAS2 upregulation, to further increase the fibrotic TME (Figure 4J). The gene discussed is YAP1; the disease is cancer.